Literature DB >> 33888458

Modelling the Anatomic Distribution of Neurologic Events in Patients with COVID-19: A Systematic Review of MRI Findings.

N Parsons1,2, A Outsikas2, A Parish2, R Clohesy2, F D'Aprano3,4, F Toomey5, S Advani6, G R Poudel7.   

Abstract

BACKGROUND: Neurologic events have been reported in patients with coronavirus disease 2019 (COVID-19). However, a model-based evaluation of the spatial distribution of these events is lacking.
PURPOSE: Our aim was to quantitatively evaluate whether a network diffusion model can explain the spread of small neurologic events. DATA SOURCES: The MEDLINE, EMBASE, Scopus, and LitCovid data bases were searched from January 1, 2020, to July 19, 2020. STUDY SELECTION: Thirty-five case series and case studies reported 317 small neurologic events in 123 unique patients with COVID-19. DATA ANALYSIS: Neurologic events were localized to gray or white matter regions of the Illinois Institute of Technology (gray-matter and white matter) Human Brain Atlas using radiologic images and descriptions. The total proportion of events was calculated for each region. A network diffusion model was implemented, and any brain regions showing a significant association (P < .05, family-wise error-corrected) between predicted and measured events were considered epicenters. DATA SYNTHESIS: Within gray matter, neurologic events were widely distributed, with the largest number of events (∼10%) observed in the bilateral superior temporal, precentral, and lateral occipital cortices, respectively. Network diffusion modeling showed a significant association between predicted and measured gray matter events when the spread of pathology was seeded from the bilateral cerebellum (r = 0.51, P < .001, corrected) and putamen (r = 0.4, P = .02, corrected). In white matter, most events (∼26%) were observed within the bilateral corticospinal tracts. LIMITATIONS: The risk of bias was not considered because all studies were either case series or case studies.
CONCLUSIONS: Transconnectome diffusion of pathology via the structural network of the brain may contribute to the spread of neurologic events in patients with COVID-19.
© 2021 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2021        PMID: 33888458      PMCID: PMC8324279          DOI: 10.3174/ajnr.A7113

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   4.966


  35 in total

1.  Critical illness-associated cerebral microbleeds in COVID-19 acute respiratory distress syndrome.

Authors:  Octave Cannac; Laurent Martinez-Almoyna; Sami Hraiech
Journal:  Neurology       Date:  2020-07-29       Impact factor: 9.910

2.  Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.

Authors:  Ling Mao; Huijuan Jin; Mengdie Wang; Yu Hu; Shengcai Chen; Quanwei He; Jiang Chang; Candong Hong; Yifan Zhou; David Wang; Xiaoping Miao; Yanan Li; Bo Hu
Journal:  JAMA Neurol       Date:  2020-06-01       Impact factor: 18.302

3.  Neurologic and neuroimaging findings in patients with COVID-19: A retrospective multicenter study.

Authors:  Stéphane Kremer; François Lersy; Mathieu Anheim; Hamid Merdji; Maleka Schenck; Hélène Oesterlé; Federico Bolognini; Julien Messie; Antoine Khalil; Augustin Gaudemer; Sophie Carré; Manel Alleg; Claire Lecocq; Emmanuelle Schmitt; René Anxionnat; François Zhu; Lavinia Jager; Patrick Nesser; Yannick Talla Mba; Ghazi Hmeydia; Joseph Benzakoun; Catherine Oppenheim; Jean-Christophe Ferré; Adel Maamar; Béatrice Carsin-Nicol; Pierre-Olivier Comby; Frédéric Ricolfi; Pierre Thouant; Claire Boutet; Xavier Fabre; Géraud Forestier; Isaure de Beaurepaire; Grégoire Bornet; Hubert Desal; Grégoire Boulouis; Jérome Berge; Apolline Kazémi; Nadya Pyatigorskaya; Augustin Lecler; Suzana Saleme; Myriam Edjlali-Goujon; Basile Kerleroux; Jean-Marc Constans; Pierre-Emmanuel Zorn; Muriel Mathieu; Seyyid Baloglu; François-Daniel Ardellier; Thibault Willaume; Jean-Christophe Brisset; Sophie Caillard; Olivier Collange; Paul Michel Mertes; Francis Schneider; Samira Fafi-Kremer; Mickael Ohana; Ferhat Meziani; Nicolas Meyer; Julie Helms; François Cotton
Journal:  Neurology       Date:  2020-07-17       Impact factor: 9.910

Review 4.  Cerebral microbleeds: overview and implications in cognitive impairment.

Authors:  Sergi Martinez-Ramirez; Steven M Greenberg; Anand Viswanathan
Journal:  Alzheimers Res Ther       Date:  2014-06-11       Impact factor: 6.982

5.  Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study.

Authors:  Aravinthan Varatharaj; Naomi Thomas; Mark A Ellul; Nicholas W S Davies; Thomas A Pollak; Elizabeth L Tenorio; Mustafa Sultan; Ava Easton; Gerome Breen; Michael Zandi; Jonathan P Coles; Hadi Manji; Rustam Al-Shahi Salman; David K Menon; Timothy R Nicholson; Laura A Benjamin; Alan Carson; Craig Smith; Martin R Turner; Tom Solomon; Rachel Kneen; Sarah L Pett; Ian Galea; Rhys H Thomas; Benedict D Michael
Journal:  Lancet Psychiatry       Date:  2020-06-25       Impact factor: 27.083

6.  The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries.

Authors:  Michael C Grant; Luke Geoghegan; Marc Arbyn; Zakaria Mohammed; Luke McGuinness; Emily L Clarke; Ryckie G Wade
Journal:  PLoS One       Date:  2020-06-23       Impact factor: 3.240

7.  Coronavirus 2019 (COVID-19)-Associated Encephalopathies and Cerebrovascular Disease: The New Orleans Experience.

Authors:  Tyler Scullen; Joseph Keen; Mansour Mathkour; Aaron S Dumont; Lora Kahn
Journal:  World Neurosurg       Date:  2020-05-28       Impact factor: 2.104

8.  COVID-19 is Associated with an Unusual Pattern of Brain Microbleeds in Critically Ill Patients.

Authors:  Aikaterini Fitsiori; Deborah Pugin; Camille Thieffry; Patrice Lalive; Maria Isabel Vargas
Journal:  J Neuroimaging       Date:  2020-07-08       Impact factor: 2.324

9.  Cerebral Microbleeds and Leukoencephalopathy in Critically Ill Patients With COVID-19.

Authors:  Shashank Agarwal; Rajan Jain; Siddhant Dogra; Penina Krieger; Ariane Lewis; Vinh Nguyen; Kara Melmed; Steven Galetta
Journal:  Stroke       Date:  2020-08-05       Impact factor: 7.914

10.  Evolution and resolution of brain involvement associated with SARS- CoV2 infection: A close Clinical - Paraclinical follow up study of a case.

Authors:  Hale Afshar; Zeynab Yassin; Saeed Kalantari; Oldooz Aloosh; Tayebeh Lotfi; Mehdi Moghaddasi; Alireza Sadeghipour; Maziar Emamikhah
Journal:  Mult Scler Relat Disord       Date:  2020-05-21       Impact factor: 4.339

View more
  8 in total

Review 1.  [COVID-19: neurological manifestations-update : What we know so far].

Authors:  Malvina Garner; W Reith; U Yilmaz
Journal:  Radiologe       Date:  2021-09-09       Impact factor: 0.803

2.  2 Years into the Pandemic: What Did We Learn About the COVID-19 and Cerebellum?

Authors:  Aasef G Shaikh; Mario Manto; Hiroshi Mitoma
Journal:  Cerebellum       Date:  2022-02       Impact factor: 3.648

Review 3.  Emerging Knowledge of the Neurobiology of COVID-19.

Authors:  Matthew Butler; Benjamin Cross; Danish Hafeez; Mao Fong Lim; Hamilton Morrin; Emma Rachel Rengasamy; Tom Pollak; Timothy R Nicholson
Journal:  Psychiatr Clin North Am       Date:  2021-11-11

4.  Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review.

Authors:  Destin Groff; Ashley Sun; Anna E Ssentongo; Djibril M Ba; Nicholas Parsons; Govinda R Poudel; Alain Lekoubou; John S Oh; Jessica E Ericson; Paddy Ssentongo; Vernon M Chinchilli
Journal:  JAMA Netw Open       Date:  2021-10-01

5.  C-reactive protein and white matter microstructural changes in COVID-19 patients with encephalopathy.

Authors:  Alexandra Rhally; Alessandra Griffa; Stéphane Kremer; Marjolaine Uginet; Gautier Breville; Patrick Stancu; Frédéric Assal; Patrice H Lalive; Karl-Olof Lövblad; Gilles Allali
Journal:  J Neural Transm (Vienna)       Date:  2021-10-28       Impact factor: 3.575

6.  Neuropsychological deficits in patients with cognitive complaints after COVID-19.

Authors:  Carmen García-Sánchez; Marco Calabria; Nicholas Grunden; Catalina Pons; Juan Antonio Arroyo; Beatriz Gómez-Anson; Alberto Lleó; Daniel Alcolea; Roberto Belvís; Noemí Morollón; Isabel Mur; Virginia Pomar; Pere Domingo
Journal:  Brain Behav       Date:  2022-02-08       Impact factor: 2.708

7.  Functional connectivity underlying cognitive and psychiatric symptoms in post-COVID-19 syndrome: is anosognosia a key determinant?

Authors:  Philippe Voruz; Alexandre Cionca; Isabele Jacot de Alcântara; Anthony Nuber-Champier; Gilles Allali; Lamyae Benzakour; Marine Thomasson; Patrice H Lalive; Karl-Olof Lövblad; Olivia Braillard; Mayssam Nehme; Matteo Coen; Jacques Serratrice; Jérôme Pugin; Idris Guessous; Basile N Landis; Dan Adler; Alessandra Griffa; Dimitri Van De Ville; Frédéric Assal; Julie A Péron
Journal:  Brain Commun       Date:  2022-03-09

8.  Monocytosis in the acute phase of SARS-CoV-2 infection predicts the presence of anosognosia for cognitive deficits in the chronic phase.

Authors:  A Nuber-Champier; P Voruz; I Jacot de Alcântara; G Breville; G Allali; P H Lalive; F Assal; J A Péron
Journal:  Brain Behav Immun Health       Date:  2022-09-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.